Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival

Transjugular intrahepatic portosystemic shunt (TIPS) implantation is an effective and safe treatment for complications of portal hypertension. Survival prediction is important in these patients as they constitute a high-risk population. Therefore, the aim of our study was to develop an alternative p...

Full description

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 74; no. 6; pp. 1362 - 1372
Main Authors Bettinger, Dominik, Sturm, Lukas, Pfaff, Lena, Hahn, Felix, Kloeckner, Roman, Volkwein, Lara, Praktiknjo, Michael, Lv, Yong, Han, Guohong, Huber, Jan Patrick, Boettler, Tobias, Reincke, Marlene, Klinger, Christoph, Caca, Karel, Heinzow, Hauke, Seifert, Leon Louis, Weiss, Karl Heinz, Rupp, Christian, Piecha, Felix, Kluwe, Johannes, Zipprich, Alexander, Luxenburger, Hendrik, Neumann-Haefelin, Christoph, Schmidt, Arthur, Jansen, Christian, Meyer, Carsten, Uschner, Frank E., Brol, Maximilian J., Trebicka, Jonel, Rössle, Martin, Thimme, Robert, Schultheiss, Michael
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.06.2021
Elsevier Science Ltd
Subjects
Online AccessGet full text
ISSN0168-8278
1600-0641
1600-0641
DOI10.1016/j.jhep.2021.01.023

Cover

More Information
Summary:Transjugular intrahepatic portosystemic shunt (TIPS) implantation is an effective and safe treatment for complications of portal hypertension. Survival prediction is important in these patients as they constitute a high-risk population. Therefore, the aim of our study was to develop an alternative prognostic model for accurate survival prediction after planned TIPS implantation. A total of 1,871 patients with de novo TIPS implantation for ascites or secondary prophylaxis of variceal bleeding were recruited retrospectively. The study cohort was divided into a training set (80% of study patients; n = 1,496) and a validation set (20% of study patients; n = 375). Further, patients with early (preemptive) TIPS implantation due to variceal bleeding were included as another validation cohort (n = 290). Medical data and overall survival (OS) were assessed. A Cox regression model was used to create an alternative prediction model, which includes significant prognostic factors. Age, bilirubin, albumin and creatinine were the most important prognostic factors. These parameters were included in a new score named the Freiburg index of post-TIPS survival (FIPS). The FIPS score was able to identify high-risk patients with a significantly reduced median survival of 5.0 (3.1–6.9) months after TIPS implantation in the training set. These results were confirmed in the validation set (median survival of 3.1 [0.9–5.3] months). The FIPS score showed better prognostic discrimination compared to the Child-Pugh, MELD, MELD-Na score and the bilirubin-platelet model. However, the FIPS score showed insufficient prognostic discrimination in patients with early TIPS implantation. The FIPS score is superior to established scoring systems for the identification of high-risk patients with a worse prognosis following elective TIPS implantation. Implantation of a transjugular intrahepatic portosystemic shunt (TIPS) is a safe and effective treatment for patients with cirrhosis and clinically significant portal hypertension. However, risk stratification is a major challenge in these patients as currently available scoring systems have major drawbacks. Age, bilirubin, albumin and creatinine were included in a new risk score which was named the Freiburg index of post-TIPS survival (FIPS). The FIPS score can identify patients at high risk and may guide clinical decision making. [Display omitted] •Risk stratification is a major challenge in patients undergoing TIPS implantation.•Age, bilirubin, albumin and creatinine emerged as the most significant predictors of 6-months survival after TIPS implantation.•These measures were summarized in a new score named the Freiburg index of post-TIPS survival (FIPS).•The FIPS score clearly identifies a high-risk group of patients with a markedly reduced survival after TIPS implantation.•Importantly, prognostic discrimination was superior to the MELD, MELD-Na, Child-Pugh score and the bilirubin-platelet model.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ISSN:0168-8278
1600-0641
1600-0641
DOI:10.1016/j.jhep.2021.01.023